This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jul 10;9(8):431.

doi: 10.1038/nrcardio.2012.97.

Atrial fibrillation: Is short-term antiarrhythmic therapy an option?

PMID: 22776985
DOI: 10.1038/nrcardio.2012.97

Comment

Atrial fibrillation: Is short-term antiarrhythmic therapy an option?

Alexandra King. Nat Rev Cardiol. 2012.

. 2012 Jul 10;9(8):431.

doi: 10.1038/nrcardio.2012.97.

Author

PMID: 22776985
DOI: 10.1038/nrcardio.2012.97

No abstract available

PubMed Disclaimer

Comment on

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
Kirchhof P, Andresen D, Bosch R, Borggrefe M, Meinertz T, Parade U, Ravens U, Samol A, Steinbeck G, Treszl A, Wegscheider K, Breithardt G. Kirchhof P, et al. Lancet. 2012 Jul 21;380(9838):238-46. doi: 10.1016/S0140-6736(12)60570-4. Epub 2012 Jun 18. Lancet. 2012. PMID: 22713626 Clinical Trial.

References

1. Lancet. 2012 Jul 21;380(9838):238-46 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.